Endogenous pain modulation in response to exercise in patients with rheumatoid arthritis, patients with chronic fatigue syndrome and comorbid fibromyalgia, and healthy controls: A double-blind randomized controlled trial

Pain Practice

Volumn 15, Issue 2, 2015, Pages 98-106

  Meeus, Mira ^a,b,c,d   Hermans, Linda ^c,d   Ickmans, Kelly ^a,b,d   Struyf, Filip ^b,d   Van Cauwenbergh, Deborah ^b,d   Bronckaerts, Laura ^a   De Clerck, Luc S ^b   Moorken, Greta ^d,e   Hans, Guy ^e   Grosemans, Sofie ^e   Nijs, Jo ^a,d,f  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d Pain in Motion Research Group   (Belgium)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Acetaminophen; Chronic fatigue syndrome; Conditioned pain modulation; Exercise induced analgesia; Fibromyalgia; Pain inhibition; Randomized controlled trial; Rheumatoid arthritis; Sensitization; Temporal summation

Indexed keywords

PARACETAMOL; PLACEBO; ANALGESIC AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; BICYCLE ERGOMETER; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; CLINICAL ARTICLE; COMORBIDITY; CONDITIONED PAIN MODULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; EXERCISE INDUCED ANALGESIA; EXERCISE TEST; FEMALE; FIBROMYALGIA; HUMAN; MIDDLE AGED; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN INHIBITION; PAIN INTENSITY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; TEMPORAL SUMMATION; ARTHRITIS, RHEUMATOID; FATIGUE SYNDROME, CHRONIC; POSTSYNAPTIC POTENTIAL SUMMATION; TREATMENT OUTCOME; YOUNG ADULT;

ACETAMINOPHEN; ADULT; AGED; ANALGESIA; ANALGESICS, NON-NARCOTIC; ARTHRITIS, RHEUMATOID; CHRONIC PAIN; COMORBIDITY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; PAIN MANAGEMENT; POSTSYNAPTIC POTENTIAL SUMMATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84922190407     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12181     Document Type: Article

References (31)

1. Kettunen JA, Kujala UM. Exercise therapy for people with rheumatoid arthritis and osteoarthritis. Scand J Med Sci Sports. 2004;14:138-142.
2. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev (Online). 2004; (3):CD003200.
3. Busch AJ, Webber SC, Brachaniec M, et al. Exercise therapy for fibromyalgia. Curr Pain Headache Rep. 2011;15:358-367.
4. Nijs J, Kosek E, Vanoosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician. 2012;15(3 Suppl):ES205-ES213.
5. Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med. 2010;42:884-890.
6. Van Oosterwijck J, Nijs J, Meeus M, et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med. 2010;268:265-278.
7. Van Oosterwijck J, Nijs J, Meeus M, Van Loo M, Paul L. Lack of endogenous pain inhibition during exercise in people with chronic whiplash associated disorders: an experimental study. J Pain. 2012;13:242-254.
8. Black CD, O'Connor PJ, McCully KK. Increased daily physical activity and fatigue symptoms in chronic fatigue syndrome. Dyn Med. 2005;4:3.
9. Sorensen B, Streib JE, Strand M, et al. Complement activation in a model of chronic fatigue syndrome. J Allergy Clin Immunol. 2003;112:397-403.
10. Meeus M, Nijs J, McGregor N, et al. Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance. In vivo (Athens, Greece). 2008;22:115-121.
11. Lapp CW. Exercise limits in chronic fatigue syndrome. Am J Med. 1997;103:83-84.
12. Nijs J, Meeus M, Van Oosterwijck J, et al. Treatment of central sensitization in patients with 'unexplained' chronic pain: what options do we have? Expert Opin Pharmacother. 2011;12:1087-1098.
13. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66:355-474.
14. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science (New York, NY). 2000;288:1765-1769.
15. Price DD, Staud R, Robinson ME, Mauderli AP, Cannon R, Vierck CJ. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 2002;99:49-59.
16. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001;91:165-175.
17. Meeus M, Nijs J, Van de Wauwer N, Toeback L, Truijen S. Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study. Pain. 2008;139:439-448.
18. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain. 1997;13:189-196.
19. Vierck CJ Jr, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD. The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain. 2001;2:334-344.
20. Lannersten L, Kosek E. Dysfunction of endogenous pain inhibition during exercise with painful muscles in patients with shoulder myalgia and fibromyalgia. Pain. 2010;151:77-86.
21. Mauger AR, Jones AM, Williams CA. Influence of acetaminophen on performance during time trial cycling. J Appl Physiol. 2010;108:98-104.
22. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600-610.
23. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953-959.
24. Bernstein MS, Morabia A, Sloutskis D. Definition and prevalence of sedentarism in an urban population. Am J Public Health. 1999;89:862-867.
25. Cathcart S, Winefield AH, Rolan P, Lushington K. Reliability of temporal summation and diffuse noxious inhibitory control. Pain Res Manag. 2009;14:433-438.
26. Meeus M, Ickmans K, Oderkerk J, et al. Does Acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial. Pain Physician. 2013;16:E61-E70; accepted for publication.
27. Wallman KE, Morton AR, Goodman C, Grove R. Physiological responses during a submaximal cycle test in chronic fatigue syndrome. Med Sci Sports Exerc. 2004;36:1682-1688.
28. Meeus M, Ickmans K, Struyf F, et al. Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial. Pain Physician. 2013;16:E61-E70.
29. Arendt-Nielsen L, Sluka KA, Nie HL. Experimental muscle pain impairs descending inhibition. Pain. 2008;140:465-471.
30. Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 2008;18:915-921.
31. Goffaux P, Redmond WJ, Rainville P, Marchand S. Descending analgesia - when the spine echoes what the brain expects. Pain. 2007;130:137-143.